Dr. Scott Harvey will complete his Post-Doctoral Fellowship with Dr. Jeffrey Miner in the Renal Division of Washington University in St. Louis, Missouri. His research will explore the importance of microRNAs in kidney development and function. MicroRNAs are regulatory molecules that act to dampen or silence gene expression. Dr. Harvey will identify microRNAs present in kidney, and will disrupt their actions using genetic strategies. His work may lead to the discovery of new pathways that are disrupted in certain kidney diseases, and in doing so, point to new therapeutic targets.
The KRESCENT Program is a Strategic Training Program developed and supported by:
With additional generous support from:
AMGEN Baxter Corporation Merck-Frosst Canada Ltd. Ortho Biotech RocheShire BioChem Inc.